ARTICLE
14 December 2023

Keith Matthews And Chris Wozniak: Talking Ag Biotech Episode 7 (Podcast)

WR
Wiley Rein
Contributor
Wiley is a preeminent law firm wired into Washington. We advise Fortune 500 corporations, trade associations, and individuals in all industries on legal matters converging at the intersection of government, business, and technological innovation. Our attorneys and public policy advisors are respected and have nuanced insights into the mindsets of agencies, regulators, and lawmakers. We are the best-kept secret in DC for many of the most innovative and transformational companies, business groups, and nonprofit organizations. From autonomous vehicles to blockchain technologies, we combine our focused industry knowledge and unmatched understanding of Washington to anticipate challenges, craft policies, and formulate solutions for emerging innovators and industries.
On this episode of Talking Ag Biotech, Keith Matthews and Chris Wozniak discuss the U.S. Department of Agriculture ...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On this episode of Talking Ag Biotech, Keith Matthews and Chris Wozniak discuss the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) Biotechnology Regulatory Services (BRS) November Stakeholders meeting. Chris also discusses the recent ESA meeting and his thoughts and insights on some of the regulatory topics that were addressed concerning the wonderful world of insects. Keith and Chris also discuss updates regarding the United States-Mexico-Canada Agreement (USMCA) genetically engineered (GE) corn trade dispute and what to expect next.

Wiley Podcast · Keith Matthews and Chris Wozniak: Talking Ag Biotech Episode 7


The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
14 December 2023

Keith Matthews And Chris Wozniak: Talking Ag Biotech Episode 7 (Podcast)

United States Food, Drugs, Healthcare, Life Sciences
Contributor
Wiley is a preeminent law firm wired into Washington. We advise Fortune 500 corporations, trade associations, and individuals in all industries on legal matters converging at the intersection of government, business, and technological innovation. Our attorneys and public policy advisors are respected and have nuanced insights into the mindsets of agencies, regulators, and lawmakers. We are the best-kept secret in DC for many of the most innovative and transformational companies, business groups, and nonprofit organizations. From autonomous vehicles to blockchain technologies, we combine our focused industry knowledge and unmatched understanding of Washington to anticipate challenges, craft policies, and formulate solutions for emerging innovators and industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More